These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32743906)

  • 1. Bullous pemphigoid without detection of autoantibodies in a patient with psoriasis under ustekinumab.
    Querol-Cisneros E; Moreno-Artero E; Rodríguez-Garijo N; Tomás-Velázquez A; Querol I; Ishii N; Hashimoto T; España A
    J Dtsch Dermatol Ges; 2021 Feb; 19(2):265-267. PubMed ID: 32743906
    [No Abstract]   [Full Text] [Related]  

  • 2. Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid.
    Kamata M; Asano Y; Shida R; Maeda N; Yoshizaki A; Miyagaki T; Kawashima T; Tada Y; Sato S
    J Dermatol; 2019 Jun; 46(6):e216-e217. PubMed ID: 30628103
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-laminin γ1 pemphigoid associated with ulcerative colitis and psoriasis vulgaris showing autoantibodies to laminin γ1, type XVII collagen and laminin-332.
    Akasaka E; Nakano H; Korekawa A; Fukui T; Kaneko T; Koga H; Hashimoto T; Sawamura D
    Eur J Dermatol; 2015 Apr; 25(2):198-9. PubMed ID: 25787875
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoantibodies against type XVII collagen C-terminal domain in a patient with bullous pemphigoid associated with psoriasis vulgaris.
    Inokuma D; Kodama K; Natsuga K; Kasai M; Abe M; Nishie W; Abe R; Hashimoto T; Shimizu H
    Br J Dermatol; 2009 Feb; 160(2):451-4. PubMed ID: 19077079
    [No Abstract]   [Full Text] [Related]  

  • 5. Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: successful disease control with cyclosporin.
    Imanishi A; Tateishi C; Imanishi H; Sowa-Osako J; Koga H; Tsuruta D; Hashimoto T
    J Dermatol; 2015 Apr; 42(4):394-7. PubMed ID: 25708520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible correlation of IgE autoantibody to BP180 with disease activity in bullous pemphigoid.
    Kamiya K; Aoyama Y; Noda K; Miyake T; Yamaguchi M; Hamada T; Tokura Y; Iwatsuki K
    J Dermatol Sci; 2015 Apr; 78(1):77-9. PubMed ID: 25771164
    [No Abstract]   [Full Text] [Related]  

  • 7. Bullous pemphigoid with hyperkeratosis and palmoplantar keratoderma: Three cases.
    Fania L; Didona D; Pacifico V; Mariotti F; De Luca N; Abeni D; Mazzanti C; Di Zenzo G; Didona B
    J Dermatol; 2018 Sep; 45(9):1135-1140. PubMed ID: 30007013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A successful treatment with ustekinumab in a case of relapsing bullous pemphigoid associated with psoriasis.
    Loget J; Plée J; Antonicelli F; Bernard P
    J Eur Acad Dermatol Venereol; 2017 May; 31(5):e228-e230. PubMed ID: 27730667
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunofluorescence-negative bullous pemphigoid sera contain antibodies mostly directed against the 180 kDa bullous pemphigoid antigen (BPAg2).
    Ghohestani RF; Claudy A
    Br J Dermatol; 1997 Aug; 137(2):306-7. PubMed ID: 9292090
    [No Abstract]   [Full Text] [Related]  

  • 10. The Anti-C1s Antibody TNT003 Prevents Complement Activation in the Skin Induced by Bullous Pemphigoid Autoantibodies.
    Kasprick A; Holtsche MM; Rose EL; Hussain S; Schmidt E; Petersen F; Panicker S; Ludwig RJ
    J Invest Dermatol; 2018 Feb; 138(2):458-461. PubMed ID: 28899686
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationships between clinical data and autoantibodies in bullous pemphigoid.
    Hashimoto T; Tsuruta D
    Br J Dermatol; 2018 Oct; 179(4):820-821. PubMed ID: 30318806
    [No Abstract]   [Full Text] [Related]  

  • 12. A successful treatment with ustekinumab in a case of antilaminin-γ1 pemphigoid associated with psoriasis.
    Majima Y; Yagi H; Tateishi C; Groth S; Schmidt E; Zillikens D; Koga H; Hashimoto T; Tokura Y
    Br J Dermatol; 2013 Jun; 168(6):1367-9. PubMed ID: 23252972
    [No Abstract]   [Full Text] [Related]  

  • 13. Rituximab decreases without preference all subclasses of IgG anti-BP180 autoantibodies in refractory bullous pemphigoid (BP).
    Ronaghy A; Streilein RD; Hall RP
    J Dermatol Sci; 2014 Apr; 74(1):93-4. PubMed ID: 24461673
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythema Multiforme-Like Bullous Pemphigoid.
    Imbernón-Moya A; Aguilar A; Burgos F; Gallego MÁ
    Actas Dermosifiliogr; 2016 Oct; 107(8):689-91. PubMed ID: 27048923
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoantibodies to bullous pemphigoid and epidermolysis bullosa acquisita antigens in an infant.
    Kawachi Y; Ikegami M; Hashimoto T; Matsumura K; Tanaka T; Otsuka F
    Br J Dermatol; 1996 Sep; 135(3):443-7. PubMed ID: 8949441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bullous pemphigoid autoantibody-mediated complement fixation is abolished by the low-molecular-weight heparin tinzaparin sodium.
    Gutjahr A; Heck F; Emtenani S; Hammers AK; Hundt JE; Muck P; Siegel DL; Schmidt E; Stanley JR; Zillikens D; Hammers CM
    Br J Dermatol; 2019 Sep; 181(3):593-594. PubMed ID: 31124130
    [No Abstract]   [Full Text] [Related]  

  • 17. Bullous pemphigoid associated with milia, increased serum IgE, autoantibodies against desmogleins, and refractory treatment in a young patient.
    Ding S; Deng Q; Xiang Y; Chen J; Huang J; Lu J
    An Bras Dermatol; 2017; 92(5 Suppl 1):34-36. PubMed ID: 29267440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological and Clinical Response to Omalizumab in a Patient with Bullous Pemphigoid.
    Menzinger S; Kaya G; Schmidt E; Fontao L; Laffitte E
    Acta Derm Venereol; 2018 Feb; 98(2):284-286. PubMed ID: 29136264
    [No Abstract]   [Full Text] [Related]  

  • 19. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid.
    Zillikens D; Mascaro JM; Rose PA; Liu Z; Ewing SM; Caux F; Hoffmann RG; Diaz LA; Giudice GJ
    J Invest Dermatol; 1997 Nov; 109(5):679-83. PubMed ID: 9347799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin E and bullous pemphigoid.
    Cozzani E; Gasparini G; Di Zenzo G; Parodi A
    Eur J Dermatol; 2018 Aug; 28(4):440-448. PubMed ID: 30325326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.